discovered that combining copanlisib, a pan‐PI3K inhibitor, and darolutamide, an AR inhibitor, synergistically enhanced DNA damage in PCa cells and promoted apoptosis [39]. The gene discussed is PIK3CD; the disease is posterior cortical atrophy.